Increased kinase activity of BCR-ABL in CD34+ CML primary cells was first confirmed by a P-crkl expression using P-crkl-FITC conjugated antibody (S4 Fig). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.